Covering Redenlab? Start here

Communication is a core human function, and measuring its decline through objective biomarkers is critical to understanding overall disease severity and functional quality of life, which is often missed by conventional assessments

Redenlab is a neuroscience clinical outcome assessment technology company founded in 2017. We specialise in the development and application of speech, language, swallowing, and audio biomarkers for clinical trials and healthcare research. Our proven digital speech platform delivers objective measurements of communication and other quality of life abilities, supporting the evaluation of treatment efficacy and ongoing patient health monitoring. Our team, which includes trained clinicians and engineers, ensures that all product development is grounded in robust science and clinical utility. Over a decade, we have partnered with a diverse range of clients, including leading pharmaceutical and biotech companies, medical clinics, and academic research institutions, solidifying our reputation as a trusted innovator in the field.